Saturday, January 31, 2026

THE GOD-KING CULT: North Korea Will Deify Kim Jong Un While Its Starving People Are Forgotten

Experts predict North Korea will enshrine Kim Jong Un's ideology in the party constitution at the upcoming 9th Workers' Party Congress.

Echoes of Freedom: South Korea Restarts Loudspeaker Psy-Ops After 6 Years

After a six-year hiatus, the South Korean military has resumed broadcasting messages via loudspeakers to North Korea.

COEXISTENCE with PESTS: South Korea’s Plan For North Korean Nuclear Threats? Just Ignore The Pests!

South Korea plans to enhance dialogue with North Korea in 2026, focusing on coexistence despite ongoing challenges in relations.

Health

How a 2-Cent Sugar Tax Could Save $4.5 Billion in Healthcare Costs: California’s Bold Move

A sugar-sweetened beverage tax in California could cut obesity cases and save $4.5 billion in healthcare costs over ten years.

Unlocking Global Potential: ezCaretech’s AI-Driven Healthcare Solutions for Saudi Arabia

ezCaretech is expanding into the Middle East, focusing on Saudi Arabia, with innovative healthcare technology and global partnerships.

Celltrion’s Zymfentra: How This Breakthrough Drug is Driving Record Sales

Celltrion expects record sales driven by Zymfentra's success, expanding into new biosimilars and CDMO business for future growth.

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Chinese Biotech’s Rise: What’s the Standard of Global Tech Trade?

Analysts at the JPMHC noted a shift in biotech, with firms resisting sales and China emerging as a tech transfer leader.
Latest

From R&D to Global Blockbuster: Fexuclue Sparks a New Vision for Daewoong

Daewoong Pharmaceutical's Fexuclue achieves rapid success with innovative marketing and aims for significant growth in treating GERD.

Fever’s Bigger Risk: Why the Tylenol Controversy Puts Moms in a Bind

Controversy surrounds acetaminophen use during pregnancy and its alleged link to autism, but evidence remains inconclusive.

Is Tylenol Dangerous for Pregnant Women? Trump’s Controversial Claims Debunked by Experts

UK Health Secretary counters Trump's claim linking Tylenol to autism, affirming its safety for pregnant women based on scientific studies.

Trump’s Next Target: Big Pharma’s Tylenol. Why He’s Questioning a $1B Industry

Trump links Tylenol to autism risk, announcing new FDA guidelines and studies, but scientific consensus remains unestablished.

Celltrion’s ‘Psoriasis’ Biosimilar Poised to Challenge Big Pharma with Phase 1 Data

The EADV conference in Paris showcased Celltrion's biosimilar CT-P55, confirming its equivalence to Cosentyx in safety and pharmacokinetics.

Bio-Revolution: Celltrion’s $700M Biosimilar Is Reshaping the Global Drug Market

Celltrion's breakthrough in antibody biosimilars is transforming healthcare, enhancing access and innovation in treatment options.

Sales and Trust: How Celltrion is Revolutionizing the European Market Directly Connected

Celltrion leverages direct sales in Europe to enhance trust and supply stability while introducing biosimilars like Omlyclo for asthma treatment.

Tylenol Stock Plunges: Trump’s Autism Warning Rattles $17B Market

Tylenol faces scrutiny over potential autism link during pregnancy, with mixed responses from the medical community and FDA caution.

Celltrion’s Biosimilar Success in Europe Paves the Way for a US Market Takeover

Celltrion's booth at EADV 2025 highlighted biosimilar innovations, showcasing promising clinical trial results and expanding treatment access.

Biosimilars No Longer Second-Best: Highlighting Cost Savings and Improved Patient Access

Biosimilars are becoming standard care, with growing confidence in their safety and efficacy, driven by cost savings and improved accessibility.

The Next Trillion-Dollar Bet: Korean Pharma Invests in Immuno-Oncology, Targeting a $1 Trillion Global Market

Cho Yong-joon outlines Dongkoo Bio's transformation into a global healthcare leader, emphasizing convergence and innovative growth strategies.

Saving Poverty vs Free Trade Society? How Celltrion’s Biosimilar Could Reshape the U.S. Healthcare Market

Professor Metz highlights biosimilars' potential to expand patient access to treatments, emphasizing Omliclo's impact at EADV conference.

New Obesity Pill Could End Wegovy’s Reign, Offering Faster and Safer Results

Ildong's ID110521156 shows promise as an affordable GLP-1 obesity drug with fewer side effects, aiming to transform the treatment landscape.

Long-Term Study Finds North Korean Defector Youth Face 30% Higher Risk of Mental Disorders

North Korean defector children face 1.3 times higher risk of mental disorders like PTSD and ADHD than South Korean peers, study finds.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.